Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct;66(10):1402-3.
doi: 10.1136/ard.2007.071878.

Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab

L B S Gelinck, Y K O Teng, G F Rimmelzwaan, B J F van den Bemt, F P Kroon, J M van Laar

Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab

L B S Gelinck et al. Ann Rheum Dis. 2007 Oct.
No abstract available

PubMed Disclaimer

References

    1. Smith N M, Bresee J S, Shay D K.et al Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006551–42. - PubMed
    1. Chalmers A, Scheifele D, Patterson C.et al Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 1994211203–1206. - PubMed
    1. Edwards J C, Szczepanski L, Szechinski J.et al Efficacy of B‐cell‐targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 20043502572–2581. - PubMed
    1. Leandro M J, Cambridge G, Ehrenstein M R, Edwards J C. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum 200654613–620. - PubMed
    1. Horwitz S M, Negrin R S, Blume K G.et al Rituximab as adjuvant to high‐dose therapy and autologous hematopoietic cell transplantation for aggressive non‐Hodgkin lymphoma. Blood 2004103777–783. - PubMed